Anti-Golgi Antibody as a Potential Indicator for Rheumatoid Arthritis

Author:

Zhai Jianzhao1ORCID,Liao Jing1,Wang Minjin1,Huang Zhuochun1,Hu Jing1,Xu Huan1,Xie Qibing2,Ma Bin3,Baan Carla C4,Wu Yongkang15

Affiliation:

1. West China School of Medicine/Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China

2. Department of Rheumatology, West China Hospital, Sichuan University, Chengdu, China

3. School of Veterinary and Life Sciences, Murdoch University, Murdoch, Australia

4. Department of Internal Medicine, Sector of Nephrology & Transplantation, Erasmus MC, Rotterdam, Netherlands

5. Department of Outpatient and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China

Abstract

Abstract Objective To reveal the relationship between anti-Golgi antibody (AGA) and clinical diseases through retrospective analysis. Methods The clinical data of 584 cases testing positive for AGA in the past 11 years were collected and retrospectively analyzed. Results AGA pattern accounted for .2% of positive ANA results. In total, 35.0% of diagnosed patients had autoimmune diseases (AID), mainly rheumatoid arthritis (RA). High-titer AGA (≧1:1000) was common in AID. In nondiagnosed patients with clinical symptoms, joint pain/muscle pain was the most common. Conclusions Positive AGA with high titer was closely related to RA. Joint pain/muscle pain was the most common symptom in patients who tested AGA positive. Therefore, AGA may be a key indicator of RA in the Chinese population.

Funder

Project of Science and Technology Department of Sichuan

Project of Science and Technology Bureau of Chengdu

Clinical Research Incubation Project, West China Hospital, Sichuan University

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Reference20 articles.

1. Anti-golgi antibodies: Prevalence and disease association in Chinese population;Ma;Clin Chim Acta.,2019

2. Evaluating the utility of autoantibodies for disease activity and relapse in giant cell arteritis;Kuret;J Biol Regul Homeost Agents.,2018

3. Challenges in the standardization of autoantibody testing: a comprehensive review;Tozzoli;Clin Rev Allergy Immunol.,2017

4. Role of autoantibody testing;Aggarwal;Best Pract Res Clin Rheumatol.,2014

5. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis;Zhang;J Immunoassay Immunochem.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3